Capital expenditure analysis
Colgate (CL) has a broad-based business in household and personal care products. Colgate’s capital expenditure for 2014 was $0.8 billion, ~13% higher than in 2013.
Colgate expects capital expenditure to come in at ~4.5% of net sales in 2015. This is higher than the historical rate of ~3.5%, primarily as a result of the expansion of its 2012 restructuring program. In 4Q12, Colgate began a four-year global growth and efficiency program for sustained growth. This was expanded in the fourth quarter of 2014 to take advantage of additional savings opportunities.
Increase in capital expenditures
Colgate’s capital expenditure as a percentage of net sales rose to 4.4% in 2014 from 3.9% in 2013. Colgate as well as competitors Procter & Gamble (PG), Clorox (CLX), and Unilever (UL) make capital spending decisions primarily to support growth plans, capacity expansions, and innovation. Capex plans are also directed towards cost controls that deliver future cash savings.
Regional capex rise
The company’s total oral, personal, and home care capital spending accounted for $0.6 billion. This was primarily due to an increase in spending in geographies like Greater Asia/Africa and North America with $0.2 billion and $0.1 billion in 2014, respectively.
The rise in capital expenditure in these regions was due to expansion of commercial hubs and optimization of global supply chain and facilities. Colgate’s moves will help the company to optimize manufacturing processes, global warehouse networks, and office locations for greater productivity and lower costs. Plus, these moves will increase the company’s speed in bringing innovations to the market.